Vancouver, British Columbia (FSCwire) - NHS Industries Ltd. (CSE:NHS)
(www.nhsindustries.ca) (“NHS” or the “Company”) wishes to announce the issuance of
5,250,000 common shares in the equity of the Company at a deemed price of $0.05 per share (the “Shares”). The Shares are
being issued as consideration for services provided by certain insiders, directors, officers, contractors and consultants who
have been working on Company matters over the course of the last several months. The Company will be providing a corporate
update shortly setting out its current objectives and plans for the Langley property and furtherance of its business plan.
About NHS
NHS owns 5.5 acres of prime agricultural land in Langley, BC that includes over 48,000 square feet of greenhouse capacity and
2700 square foot caretaker’s residence. The Langley Campus was recently spun out from its former parent – New Age Farm
Inc. For further information about NHS, please consult the Company’s profile on SEDAR at www.sedar.com.
###
On Behalf of the Board of Directors
Carman Parente
President and Chief Executive Officer
info@nhsindustries.ca
(888) 202-5153
WWW.NHSINDUSTRIES.CA
This news release contains forward-looking statements, which relate to future events or future performance and reflect
management’s current expectations and assumptions. Such forward-looking statements reflect management’s current beliefs and are
based on assumptions made by and information currently available to the Company. Readers are cautioned that these forward looking
statements are neither promises nor guarantees, and are subject to risks and uncertainties that may cause future results to
differ materially from those expected including, but not limited to completion of planned improvements on schedule and on budget,
the availability of financing needed to complete the Company’s planned improvements on commercially reasonable terms, delays in
obtaining statutory and/or regulatory approval for production plans, the ability to mitigate the risk of loss through appropriate
insurance policies, among others. These forward-looking statements are made as of the date hereof and the Company does not assume
any obligation to update or revise them to reflect new events or circumstances save as required under applicable securities
legislation. This news release does not constitute an offer to sell securities and the Company is not soliciting an offer to buy
securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification
under the securities laws of such jurisdiction.
This news release does not constitute an offer of securities for sale in the United States. These securities have not and
will not be registered under United States Securities Act of 1933, as amended, or any state securities laws and may not be
offered or sold in the United States or to a U.S. Person unless so registered, or an exemption from registration is relied
upon.
The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release and accepts no
responsibility for the adequacy or accuracy hereof.
To view the original release, please click here
Source: NHS Industries Ltd. (CSE:NHS)
To follow NHS Industries Ltd. on your favorite social media platform or financial websites, please click on the icons
below.
Maximum News Dissemination by FSCwire. https://www.fscwire.com
Copyright © 2018 FSCwire